Cancer patients missing out on best treatment because of cost

Cancer patients are missing out on high-tech radiotherapy because the NHS is struggling to invest in staff and technology.Intensity modulated radiotherapy, which has been used in Europe and the US for a decade, is used to treat only 7 per cent of eligible NHS patients, according to research by the ...

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here